Business

AxisBiotix-PsT Psoriasis Food Supplement Launch

AxisBiotix-PsT Psoriasis Food Supplement Launch.

articleSkinbiotherapeutics PlcSeptember 30, 20213/company/skinbiotherapeutics-plc/news/axisbiotix-pst-psoriasis-food-supplement-launch
AxisBiotix-PsT Psoriasis Food Supplement Launch

About this update from Skinbiotherapeutics Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 4444N\n SkinBioTherapeutics PLC\n 30 September 2021\n  \n \n \n \n 30 September 2021\n \n \n  \n \n \n SkinBioTherapeutics plc\n \n \n (\"SkinBioTherapeutics\" or \"the Company\")\n \n \n  \n \n \n AxisBiotix-Ps™ Psoriasis Food Supplement Launch and Progress Update\n \n \n · \n AxisBiotix-Ps™ to launch on World Psoriasis Day - 29 October 2021;\n \n \n · \n Finished product ready in Netherlands distribution centre\n \n \n · \n Pre-registrations for \n \n AxisBiotix-Ps \n \n continue to increase\n \n \n  \n \n \n SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, has today provided a significant update on its commercialisation plans for \n AxisBiotix-Ps™, its \n probiotic food supplement\n  \n to help alleviate the symptoms associated with psoriasis,\n and reveals the launch date as 29 October 2021, which notably is World Psoriasis Day.\n \n \n  \n \n \n Following highly positive results from its \n \n consumer study in May 2021\n \n , SkinBioTherapeutics has driven ahead the finalisation of the regulatory pathway and commercial strategy for AxisBiotix-Ps\n ™\n . Key activities have included the preparation of and warehousing the finished product and commencing marketing prior to the upcoming launch, as well as establishing a supply chain.\n \n \n  \n \n \n Through its subsidiary AxisBiotix Limited (\"AxisBiotix\"), SkinBioTherapeutics has begun receiving and storing finished product at its distribution centre in the Netherlands. The warehouse is 10,000sq metres and is located in Boxtel near Eindhoven which has been carefully chosen for its proximity to the Company's formulation partner, Winclove and its distribution links to the US, UK and Europe. Readying of finished product is ahead of schedule for launch.\n \n \n  \n \n \n Commercialisation will commence with a 'soft launch' of AxisBiotix-Ps™ on World Psoriasis Day,\n29 October 2021. As previously announced, commercialisation will start in the UK and the US markets. Sales of the product will be restricted initially to a limited number of customers from the pre-registration list to ensure a robust and reliable supply chain. Thereafter access to the eCommerce website will be opened up on a broader basis to the remainder of the waiting list and the wider psoriatic population.  \...

More updates from Skinbiotherapeutics Plc